Skip to main content
Floor vote

Senate vote #38

On the Motion to Table S.Amdt. 1708 to H.R. 4210 (Tax Fairness and Economic Growth Act of 1992)

To provide for the containment of prescription drug prices by reducing certain non-research related tax credits to pharmaceutical manufacturers, by establishing the Prescription Drug Policy Review Commission, be requiring a study of the feasibility of establishing a pharmaceutical products price … Read full descriptionHide

To provide for the containment of prescription drug prices by reducing certain non-research related tax credits to pharmaceutical manufacturers, by establishing the Prescription Drug Policy Review Commission, be requiring a study of the feasibility of establishing a pharmaceutical products price review board, and by requiring a study of the value of Federal subsidies and tax credits given to pharmaceutical manufacturers, and for other purposes.

Agreed To Congress 102 · Session 2 Mar 11, 1992 · 5:50 PM EST  HR 4210
AGREED TO
61–36
+25 margin
Democrats
20 34
Republicans
41 2
Majority threshold YES 61 36 NO
97 members voted · 3 Not Voting Passed by 25 votes
 Voted yes 2
Report a problem